An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1

被引:9
|
作者
Hutter, P [1 ]
Wijnen, J
Rey-Berthod, C
Thiffault, I
Verkuijlen, P
Farber, D
Hamel, N
Bapat, B
Thibodeau, SN
Burn, J
Wu, J
MacNamara, E
Heinimann, K
Chong, G
Foulkes, WD
机构
[1] Hop Valaisans, Inst Cent, Genet Unit, Sion, Switzerland
[2] Leiden Univ, Med Ctr, Dept Human & Clin Genet, Leiden, Netherlands
[3] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Diagnost Med, Montreal, PQ, Canada
[4] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Med, Montreal, PQ, Canada
[5] McGill Univ, Sir MB Davis Jewish Gen Hosp, Dept Oncol, Montreal, PQ, Canada
[6] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada
[7] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada
[8] Mayo Clin, Mol Genet Lab, Rochester, MN USA
[9] Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[10] St Marys Hosp, NW Reg Genet Lab, Manchester M13 0JH, Lancs, England
[11] Univ Clin, Div Med Genet, Res Grp Human Genet, Basel, Switzerland
[12] McGill Univ, Dept Oncol & Human Genet, Program Canc Genet, Montreal, PQ, Canada
关键词
D O I
10.1136/jmg.39.5.323
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: The mismatch repair gene, MLH1, appears to occur as two main haplotypes at least in white populations. These are referred to as A and G types with reference to the A/G polymorphism at IVS14-19. On the basis of preliminary experimental data, we hypothesised that deviations from the expected frequency of these two haplotypes could exist in carriers of disease associated MLH1 germline mutations. Methods: We assembled a series (n = 119) of germline MLH1 mutation carriers in whom phase between the haplotype and the mutation had been conclusively established. Controls, without cancer, were obtained from each contributing centre. Cases and controls were genotyped for the polymorphism in IVS14. Results: Overall, 66 of 119 MLH1 mutations occurred on a G haplotype (55.5%), compared with 315 G haplotypes on 804 control chromosomes (39.2%, p=0.001). The odds ratio (OR) of a mutation occurring on a G rather than an A haplotype was 1.93 (95% Cl 1.29 to 2.91). When we compared the haplotype frequencies in mutation bearing chromosomes carried by people of different nationalities with those seen in pooled controls, all groups showed a ratio of A/G haplotypes that was skewed towards G, except the Dutch group. On further analysis of the type of each mutation, it was notable that, compared with control frequencies, deletion and substitution mutations were preferentially represented on the G haplotype (p=0.003 and 0.005, respectively). Conclusion: We have found that disease associated mutations in MLH1 appear to occur more often on one of only two known ancient haplotypes. The underlying reason for this observation is obscure, but it is tempting to suggest a possible role of either distant regulatory sequences or of chromatin structure influencing access to DNA sequence. Alternatively, differential behaviour of otherwise similar haplotypes should be considered as prime areas for further study.
引用
收藏
页码:323 / 327
页数:5
相关论文
共 50 条
  • [1] Retained Colorectal Carcinoma MLH1 Expression in Lynch Syndrome Patients Carrying a Germline MLH1 Mutation
    Rosty, Christophe
    Clendenning, Mark
    Win, Aung
    Casey, Graham
    Haile, Robert
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly
    Paller, John
    Lindor, Noralane
    DeRycke, Melissa
    Thibodeau, Stephen
    Hopper, John
    Jenkins, Mark
    Buchanan, Daniel
    [J]. MODERN PATHOLOGY, 2015, 28 : 188A - 188A
  • [2] Retained Colorectal Carcinoma MLH1 Expression in Lynch Syndrome Patients Carrying a Germline MLH1 Mutation
    Rosty, Christophe
    Clendenning, Mark
    Win, Aung
    Casey, Graham
    Haile, Robert
    Gallinger, Steve
    Le Marchand, Loic
    Newcomb, Polly
    Potter, John
    Lineor, Noralane
    DeRycke, Melissa
    Thibodeau, Stephen
    Hopper, John
    Jenkins, Mark
    Buchanan, Daniel
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 188A - 188A
  • [3] An American founder mutation in MLH1
    Tomsic, Jerneja
    Liyanarachchi, Sandya
    Hampel, Heather
    Morak, Monika
    Thomas, Brittany C.
    Raymond, Victoria M.
    Chittenden, Anu
    Schackert, Hans K.
    Gruber, Stephen B.
    Syngal, Sapna
    Viel, Alessandra
    Holinski-Feder, Elke
    Thibodeau, Stephen N.
    de la Chapelle, Albert
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (09) : 2088 - 2095
  • [4] Mutator phenotypes conferred by MLH1 overexpression and by heterozygosity for mlh1 mutations
    Shcherbakova, PV
    Kunkel, TA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1999, 19 (04) : 3177 - 3183
  • [5] Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation
    Hanifa Bouzourene
    Pierre Hutter
    Lorena Losi
    Patricia Martin
    Jean Benhattar
    [J]. Familial Cancer, 2010, 9 : 167 - 172
  • [6] Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation
    Bouzourene, Hanifa
    Hutter, Pierre
    Losi, Lorena
    Martin, Patricia
    Benhattar, Jean
    [J]. FAMILIAL CANCER, 2010, 9 (02) : 167 - 172
  • [7] MLH1 gene duplication detected by MLPA in an HNPCC patient
    Fisher, S
    Payne, SJ
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 : S76 - S76
  • [8] MLH1 and PMS2 protein expression in 103 colorectal carcinomas with MLH1 promoter methylation and without MLH1 or PMS2Germline mutation
    Mahooti, S
    Hampel, H
    LaJeunesse, J
    Sotamaa, K
    de la Chapelle, A
    Frankel, WL
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 113A - 113A
  • [9] MLH1 and PMS2 protein expression in 103 colorectal carcinomas with MLH1 promoter methylation and without MLH1 or PMS2 germline mutation
    Mahooti, S
    Hampel, H
    LaJeunesse, J
    Sotamaa, K
    de la Chapelle, A
    Frankel, WL
    [J]. MODERN PATHOLOGY, 2006, 19 : 113A - 113A
  • [10] A nonsense mutation in MLH1 causes exon skipping in three unrelated HNPCC families
    Stella, A
    Wagner, A
    Shito, K
    Lipkin, SM
    Watson, P
    Guanti, G
    Lynch, HT
    Fodde, R
    Liu, B
    [J]. CANCER RESEARCH, 2001, 61 (19) : 7020 - 7024